Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29723046 | 0.93 | TSHR (0.65) | TSHRSMN1; SMN2CA1CA2CA9 | |
| SCHEMBL29722937 | 0.85 | TSHR (0.38) | TSHRSMN1; SMN2 | |
| SCHEMBL575212 | 0.81 | PPARD (0.37) | TSHRSMN1; SMN2PPARD | |
| SCHEMBL576230 | 0.80 | TSHR (0.35) | TSHRSMN1; SMN2HTTCA1CA2 | |
| SCHEMBL778819 | 0.79 | TSHR (0.46) | TSHRSMN1; SMN2CA1CA2CA9 | |
| SCHEMBL575606 | 0.79 | SMN1; SMN2 (0.36) | SMN1; SMN2HTTCA1CA2CA9 | |
| SCHEMBL575431 | 0.78 | TSHR (0.33) | TSHRSMN1; SMN2HTTCA1CA2 | |
| SCHEMBL575490 | 0.78 | CYP3A4 (0.37) | TSHRSMN1; SMN2PPARD | |
| SCHEMBL29723023 | 0.76 | ACHE (0.39) | TSHR | |
| SCHEMBL2701494 | 0.76 | PPARD (0.35) | TSHRSMN1; SMN2HTTPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4666334-A2 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| US-20250273736-A1 | FLEXIBLE BATTERY | Anthro Energy, Inc. (US) | 2025-08-28 | — | — | US | claimed |
| US-12191447-B2 | Gel electrolyte composition for a battery and a method of implementation | Anthro Energy, Inc. (US) | 2025-01-07 | — | — | US | claimed |
| US-20240283017-A1 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2024-08-22 | — | — | US | claimed |
| WO-2024173770-A2 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2024-08-22 | — | — | WO | claimed |
| CN-115084635-A | Secondary battery electrolyte and preparation method and application thereof | 湖南法恩莱特新能源科技有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-216872188-U | High-capacity battery shell | 陕西奥林波斯电力能源有限责任公司 | 2022-07-01 | — | — | CN | claimed |
| CN-216536633-U | Heat pipe containing gas production device for battery | 陕西奥林波斯电力能源有限责任公司 | 2022-05-17 | — | — | CN | claimed |
| CN-216432631-U | Self-venting explosion heat pipe for battery | 陕西奥林波斯电力能源有限责任公司 | 2022-05-03 | — | — | CN | claimed |
| CN-113972415-A | Heat pipe containing phosphorus flame retardant for high-capacity battery | 陕西奥林波斯电力能源有限责任公司 | 2022-01-25 | — | — | CN | claimed |
| CN-113908470-A | Heat pipe containing gas production device for battery and fire extinguishing method thereof | 陕西奥林波斯电力能源有限责任公司 | 2022-01-11 | — | — | CN | claimed |
| CN-113794029-A | High-capacity battery shell | 陕西奥林波斯电力能源有限责任公司 | 2021-12-14 | — | — | CN | claimed |
| CN-113566621-A | Self-venting explosion heat pipe for battery | 陕西奥林波斯电力能源有限责任公司 | 2021-10-29 | — | — | CN | claimed |
| EP-4666334-A2 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | APPLE INC. (US) | 2025-06-17 | — | — | US | disclosed |
| US-20250087748-A1 | GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION | Anthro Energy, Inc. (US) | 2025-03-13 | — | — | US | disclosed |
| EP-1567524-A1 | THIA-EPOTHILONE DERIVATIVES FOR THE TREATMENT OF CANCER | Richter, Wolfgang (DE) | 2005-08-31 | — | — | EP | disclosed |
| EP-1521752-A1 | NOVEL MACROCYCLES FOR THE TREATMENT OF CANCER | Gesellschaft fur Biotechnologische Forschung mbH (gbf) (DE) | 2005-04-13 | — | — | EP | disclosed |
| WO-2004048372-A1 | THIA-EPOTHILONE DERIVATIVES FOR THE TREATMENT OF CANCER | MORPHOCHEM AG KOMB CHEMIE (DE) | 2004-06-10 | — | — | WO | disclosed |
| WO-2004007492-A1 | NOVEL MACROCYCLES FOR THE TREATMENT OF CANCER | GESELLSCHAFT FUER BIOTECHNOLGISCHE FORSCHUNG MBH (GBF) (DE) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | CEL, CA3, SLC9B2 | TSHR 3117/4885SMN1; SMN2 2474/4885HTT 2821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.